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Abstract
OBJECTIVE: To study on effects of Lichong decoc-
tion on expression of apoptosis-controlling genes,
Bcl-2 and Bcl-2-associated X protein (Bax) mRNAs in
hysteromyoma tissue of the hysteromyoma model
rat.
METHODS: Fifty Wistar female rats were randomly
divided into a normal group, a model group, a Li-
chong decoction group, a Guizifuling capsule
group and a Mifepristone group. The hysteromyo-
ma rat model was established by intraperitoneal in-
jection of exogenous estrin and progestogens.
Pathological examination of uterine tissue, uterine
coefficient and uterine transverse diameter were
made under optic microscope and expressions of
Bcl-2 and Bax mRNAs in uterine tissue in the
groups were detected with real-time fluorescent
quantitative polymerase chain reaction (PCR) tech-
nique.
RESULTS: After treatment, under microscope it was
found that in the Lichong decoction group myome-
trium thinned, muscle fiber slightly overgrowth or
long and thin, regular arrangement, inserting phe-
nomenon of inner circular muscle and external lon-
gitudinal muscle was occasionally or not seen in
the Lichong decoction group. The uterine coeffi-
cient and the uterine transverse diameter signifi-
cantly decreased (P<0.01), and Bcl-2 mRNA expres-
sion significantly decreased (P<0.01) and Bax
mRNA expression significantly increased in hystero-
myoma tissue (P<0.01) in the Lichong decoction
group as compared with the model group.
CONCLUSION: Therapeutic effects of Lichong de-
coction on hysteromyoma is related with decrease
of Bcl-2 mRNA expression and increase of Bax
mRNA expression.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Hysteromyoma is a commonly and frequently encoun-
tered disease of female reproductive system, severely in-
fluencing female health and quality of life. Lichong de-
coction originates from Interpretation of Medical Prob-
lems by Combined Chinese and Western Medicine
written by Mr. Xichun Zhang, a famous physician in
the Qing Dynasty, which has functions of strengthen-
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ing genuine Qi and removing blood stasis and is used
for treatment of hysteromyoma and other gynecopa-
thies with better clinical therapeutic effects, but the
pharmacologic effect is not very clear. A study indicates
that production and development hysteromyoma is
closely related with abnormal expression of apopto-
sis-regulating genes,1 Bcl-2 and Bcl-2-associated X pro-
tein (Bax) form positive and negative regulation of
apoptosis, over high Bcl-2 expression level and over
lower Bax expression level are molecular basis of pro-
duction and development of hysteromyoma. In the
present study, effects of Lichong decoction on expres-
sion of Bcl-2 and Bax mRNAs in hysteromyoma tissue
of the hysteromyoma rat were investigated by real-time
fluorescent polymerase chain reaction (PCR) tech-
nique, so as to probe into the mechanism of Lichong
decoction in treatment of hysteromyoma from molecu-
lar level, providing experimental basis for clinical treat-
ment.
MATERIALS ANDMETHODS
Experimental animals
Fifty Wistar rats, female, health, adult, un-pregnancy,
weighing (220±20) g, SPF grade, were purchased from
Academy of Military Medical Sciences, Certificate of
quality No. SCXK (Army) 2007-0004, and they were
fed in the animal room of SPF grade, the Experimental
Animal Department, Capital Medical University, with
normal illumination, free access to food and water, at
room temperature of 18℃-22℃.
Medicines for modeling Estradiol benzoate Injection:
Tianjin Jinyao Amino Acid Co. Ltd., Batch No.
0703121, 1 mg/mL; Progesterone Injection: Shanghai
Tongyong Pharmaceutical Co. Ltd., Batch No.
070902, 20 mg/mL.
Drugs for investigation Lichong decoction was com-
posed of crude Huangqi (Radix Astragali ) 9 g, Dangsh-
en (Radix Codonopsis) 6 g, Baizhu (Rhizome Atractylodis
Macrocephalae) 6 g, fresh Shan Yao (Rhizome Dioscore-
ae) 15 g, Tianhuafen (Radix Trichosanthis) 12 g, Zhimu
(Rhizome Anemarrhenae) 12 g, Sanleng (Rhizome Spar-
ganii) 9 g, Ezhu (Rhizoma Curcumae) 9 g, fresh Jineijin
(Endothelium Corneum Gigeriae Galli) 9 g, which were
purchased from Beijing Tong Ren Tang Prepared Herb-
al Pieces Co. Ltd., and were extracted twice with water
and prepared a concentrated solution containing crude
drugs 3.3 g/mL, kept at 0℃-4℃ , and the dosage was
22 g/kg per day for the animal with mixed before use;
Gui Zhi Fu Ling capsules, Jiangsu Kangyuan Pharma-
ceutical Co. Ltd. Batch No.: 080305, was dissolved in
distilled water and prepared a solution of 0.10 g/mL,
and the dosage was 0.70 g/kg per day for the animal;
Mifepristone, Zhejiang Xianju Pharmaceutical Co.
Ltd. batch No.: 080501, was dissolved in distilled wa-
ter and prepared a solution of 0.94 mg/mL, and the
dosage of was 6.25 mg/kg per day.
Main reagents and equipments: fermentas K1622 RT
reverse transcription kit (Mbi, California, USA); SYBR
Green PCR Master Mix (Abi, North Carolina, USA);
TRIZOL reagent (Invitrogen life technologies, Califor-
nia, USA); PRISM 5700 fluorescent quantitative PCR
meter (Abi, North Carolina, USA); DU-600 spectro-
photometer (Beckman, California, USA); high speed
refrigerated centrifuge (Beckman, California, USA).
Modeling and administration
The animals were conveniently fed for one week and
were randomly divided into two groups by random
number table, a normal control group (n=10) and a
modeling control group (n=40). They were fed in sepa-
rated cages with free access to water and food. The rats
in the modeling group were intraperitoneally injected
with estradiol benzoate injection, 0.5 mg/kg, once a
day for 25 consecutive days and then with progester-
one injection, 4 mg/kg,once each day for 5 consecutive
days. After end of modeling, the model rats were ran-
domly divided into a model control group, a Lichong
decoction group, a Guizifuling capsule group and a
Mifepristone group by random number table. The rats
in the medical groups were intragastrically administrat-
ed once each day in 2-fold adult dosage. The rats in
the normal control and the model control group were
administrated intragastrically with equal volume of dis-
tilled water for 4 consecutive weeks.
Experimental methods
The rats were weighed and hair color and automatic ac-
tivity were observed each week. After administration
for 4 weeks, the rats were fasted for 12 h over night,
with free access to water and the body weight was
weighed, and then anesthetized with 30% chloral hy-
drate (3 mL/kg ) ip, and the uterus was weighed.The
indexes and methods investigated are showed as fol-
lows.
Pathological examination
The uterine segment of same part 0.5 cm above the
uterine dividing horn was taken and fixed with 10%
neutral formalin, and embedded with paraffin and sec-
tioned, HE staining and observed under a microscope.
Uterine coefficient and uterine transverse diameter
detection
Uterine coefficient (mg/g): uterine weight/body weight
of rat.
Uterine transverse diameter: the transverse diameter
bellow the uterine dividing horn (above the uterine
neck) and the root of the dividing horn (the uterine
root of dividing horn on one side) was measured.
Real-time fluorescent quantitative PCR
Amount of 50-100 mg uterine tissue of same part
above the uterine dividing horn was added with 1 mL
TRIZOL reagent, and Real-time PCR primer was de-
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signed and analyzed, and gene oder of the primer was
achieved from gene bank and Primer Expression 3.0
software was used for auxiliary design of computer.
The gene orders are showed is shown in Table 1.
RNA in the detected sample was extracted and qualita-
tively detected, and was reversely transcribed as cDNA
by using Fermentas K1622 RT reverse transcription
kit; Standard curve samples were prepared, and ampli-
fied and detected by Real-Time PCR at 95℃ 5 min;
95℃ 30 s, 53℃ 30 s, 72℃ 50 s, 40 cycles; 72℃ 8 min.
After end of reaction, CT values of the samples were
detected. The mixed cDNA solution after the reverse
transcription was used as standard sample, which was
diluted in 10-fold gradient dilution. The linear relative
quantitative standard curve based on 5 points was con-
structed by drawing a lattice figure of each standard
CT value (Y axis) and corresponding Log value (X ax-
is) of total RNA amount , and then RNA levels of
Bcl-2, Bax and β-actin of each sample were calculated
on the basis of the standard curve , and RNA levels of
Bcl-2 and Bax genes were corrected with β-actin RNA
level, their ratio was relative expression amount of
Bcl-2 and BaxmRNAs in each sample.
Statistical methods
Quantitative data were expressed as mean±standard de-
viation. SPSS 13.0 software (SPSS, Chicago, IL, USA)
was used for detection of normal distribution of the da-
ta. For the data conforming to normal distribution,
One-way ANOVA was used for comparison between
groups, LSD method was used for equal variance as-
sumed and Tamhane's T2 method was used for equal
variance not assumed;For the data in-conforming to
normal distribution, Kruskal-Wallis H test was adopt-
ed. P<0.05 was used as the limitation of statistical sig-
nificance.
RESULTS
Pathological detection
Under microscope (HE ×200): in the normal control
group uterine muscular layer was thin, muscle fiber
had no proliferation and hypertrophy, inner circular
muscle and external longitudinal muscle regularly ar-
ranged (Figure 1A); In the model control group the
uterine muscle fiber had obvious proliferation and hy-
pertrophy, the muscular layer obviously thickened and
the muscle fiber arranged irregularly showing a slight
network form or a whirlpool form, approaching to lio-
myoma-like proliferation, indicating the modeling is
successful (Figure 1B); In the Lichong decoction group
the uterine muscular layer obviously thinned, the mus-
cle fiber had slight hypertrophy or long and thin, and
arranged regularly, inserting phenomenon of inner cir-
cular muscle and external longitudinal muscle occasion-
ally was seen or was not seen (Figure 1C). In the Guiz-
ifuling capsule group the muscle fiber had slight prolif-
eration and hypertrophy, muscular layer slightly thick-
ened, and the inserting phenomenon of inner circular
muscle and external longitudinal muscle was occasion-
ally seen (Figure 1D). In the Mifepristone group uter-
ine muscle fiber had proliferation and hypertrophy, the
muscular fiber arranged slightly-irregularly, a part of
them showed whirlpool form (Figure 1E).
Figure 1 Pathological changes of uter-
ine muscle under microscope among
groups (HE ×200)
HE: hematoxylin eosin.
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Gene
β-actin
Bcl-2
Bax
Orders of primer
Upstream
Downstream
Upstream
Downstream
Upstream
Downstream
5' gagaccttcaacaccccagcc 3'
5' aatgtcacgcacgatttccc 3'
5' gggatgcctttgtggaacta 3'
5' atttgtttggggcaggtct 3'
5' agacacctgagctgaccttg3'
5' aagttgccatcagcaaacat 3'
Table 1 Gene oders of the primer
Note: Bax：Bcl-2-associated X protein.
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Uerine coefficient and transverse diameter
The uterine coefficient and transverse diameter in the
model control group were significantly increased as
compared with the normal control group (P<0.01),
and in the Lichong decoction group and the Guiziful-
ing capsule group significantly decreased as compared
with the model control group (P<0.01), and in the
uterine coefficient there was significant difference be-
tween the Mifepristone group and the model control
group (P<0.01) with no significant difference in the
uterine transverse diameter (Table 2).
Lichong decoction effect on expressions of Bcl-2 and
Bax mRNAs
PCR amplified products: the results of 1.2% agarose
gel electrophoresis indicated that the specific strip-
zones for β-actin (264 bp), Bcl-2 (163 bp ) and Bax
(193 bp) were bright and visible , suggesting that the
amplified fragments are accurate (Figure 2).
Relative expression amount of Bcl-2 and Bax mRNA
in the groups: as compared with the normal control
group, Bax mRNA expression in the model control
group significantly decreased (P<0.01) and expression
of Bcl-2 mRNA significantly increased (P<0.01); As
compared with the model control group, Bcl-2mRNA
expression in the Lichong decoction group and the
Mifepristone group significantly decreased (P<0.01)
and Bax mRNA expression significantly increased (P<
0.01), in the Guizhifuling capsule group Bcl-2 mRNA
expression significantly decreased (P<0.05) and Bax
mRNA expression significantly increased (P<0.01)(Ta-
ble 3).
DISCUSSION
Hysteromyoma belongs to the category of "stony uter-
ine mass", "female abdominal mass", etc. in TCM.
TCM holds that"blood stasis" is the main pathogenesis
of this disease, with pathological basis of insufficient
genuine Qi. For its treatment, supplementing Qi, rein-
forcing kidney, activating blood circulation and remov-
ing blood stasis are commonly used methods. Strength-
ening genuine Qi to remove blood stasis has good clini-
cal effects on early Hysteromyoma. Lichong decoction
originates from Yi Xue Zhong Zhong Can Xi Lu written
by Mr. Xichuan Zhang, a famous physician in the
Qing Dynasty, which is a represent formula treating
hysteromyoma with the therapeutic principle of
strengthening genuine Qi to remove blood stasis . In
the formula , Shenghuangqi (Radix Astragali), Dan-
gchen (Radix Codonopsis), Baizhu (Rhizome Atractylodis
Macrocephalae), and Shengshanyao (Rhizome Dioscore-
ae) have functions of supplementing Qi and strengthen-
ing spleen , and Sanleng (Rhizome Sparganii), Ezu (Rhi-
zoma Curcumae), Shengjineijin (Endothelium Corneum
Gigeriae Galli) have functions of disintegrating masses ,
dispersing accumulation of pathogen, and Tianhuafen
(Radix Trichosanthis) functions nourishing Yin and re-
moving toxic substances, Zhimu (Rhizoma Anemarrhe-
nae) has function of cooling-moistening. The whole
Notes: Compared with the model control group, aP<0.01; bP<0.05; .
Table 2 Comparison of uterine coefficient and transverse diameter among the groups (n=10, xˉ ± s )
Group
Normal control
Model control
Lichong
Guizhifuling capsule
Uterine coefficient
2.5±0.6a
6.9±1.2
2.6±0.4a
2.5±0.6a
Uterine transverse diameter (mm)
Diameter below the dividing horn
4.8±1.0a
7.8±1.1
5.0±0.7a
6.1±0.9a
Diameter of the root of the dividing horn
2.6±0.7a
4.9±1.1
3.4±0.7a
3.0±0.8a
Group
Normal control
Model control
Lichong decoction
Guizifuling capsule
Mifepristone
Bcl-2
1.05±0.07a
1.49±0.12
1.21±0.06a
1.32±0.04b
1.28±0.06a
Bax
1.16±0.08a
0.87±0.09
1.28±0.11a
1.13±0.06a
1.41±0.14a
Table 3 Comparison of Bcl-2 and Bax mRNAs expressions
among the groups (n=10, xˉ ± s )
Notes: Bax：Bcl-2-associated X protein. Compared with the
model control group, aP<0.01; bP<0.05.
264
1 2 3 4 5 6 7 8 9 10 11
β-actin
bpA
1 2 3 4 5 6 7 8 9 10 11
163Bcl-2
B
1 2 3 4 5 6 7 8 9 10 11
193Bax
C
Figure 2 PCR amplified products in the groups
1: maker; 2, 3: model control group; 4, 5: Lichong decoction
group; 6, 7: Guizhifuling capsule group; 8, 9:Mifepristone; 10,
11: normal control.
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formula reflects both strengthening nenuine Qi and
eliminating pathogenic factors, eliminating masses
without injuring the genuine Qi, and supplementing
Qi and blood without hindering elimination of masses.
In previous study, we used a modified Lichong decoc-
tion composing of the Chinese drugs for strengthening
genuine Qi and removing blood stasis and found they
had obvious inhibiting action on hysteromyoma.2 In or-
der to further probe into pharmacologic mechanisms
of this drug, in the study effects of Lichong decoction
on apoptosis-regulating genes Bcl-2 and Bax mRNAs
in the hysteromyoma model rat.
Occurrence of hysteromyoma is a complex course in-
volved in multi-factors and multi-stages. In recent
years studies have indicated that occurrence of hystero-
myoma is possibly induced by imbalance between
apoptosis and proliferation.3,4 Apoptosis is a mecha-
nism of initiative, physiologic death of cell-self, and
the apoptotic course is regulated commonly by both
apoptosis-promoting factor and apoptosis-inhibiting
factor. Occurrence of tumor is induced not only by
strengthening of cellular proliferation, but also de-
crease of cell death. When apoptosis is inhibited, cells
abnormally proliferate, finally, forming focal mass or
tumor . Bcl-2 and Bax are a pair of cytokines of regulat-
ing cell proliferation and apoptosis, belonging to the
same family of Bcl-2, and they are genes closely related
with occurrence of human many tumors. Bcl-2 gene is
one of oncogenes of the most attaching attention in
studies of apoptosis, and Bcl-2 gene family includes 17
members such as Bcl-2/Bax, Bcl-XL/Bcl-Xs, Bak, etc.
They interact and are commonly involved in the
course regulating apoptosis, among them, action of
Bcl-2/Bax is particularly important. Bcl-2 protein is
mainly located in mitochondrion and rough endoplas-
mic reticulum of cell membrane, and it has anti-apop-
tosis action through prolonging the living cycle of cells
and strengthening the tolerance of cells to apoptosis
stimulating factors. Bax has 6 extrons, which respective-
ly transcribe as 3 kinds of RNA, code the 3 kinds of
proteins, Bax a, Bax b, Bax y. Main biologic functions
of Bax is accelerating apoptosis, with tumor-inhibiting
action. Bcl-2 and Bax form positive and negative regu-
lation of apoptosis. Over expression of Bcl-2 inhibits
apoptosis; over expression of Bax can promote apopto-
sis. Their ratio determine amount of apoptosis. Over
expression of Bcl-2 and over low expression of Bax are
molecular basis of occurrence and development of hys-
teromyoma.5,6
The results in the study indicate that compared with
the normal control group, Bax mRNA expression sig-
nificantly decreases (P<0.01), Bcl-2 mRNA expression
significantly increases (P<0.01) in the model control
group, suggesting that occurrence of hysteromyoma
has the molecular basis of over high Bcl-2 expression
and over low Bax expression. Compared with the mod-
el control group, Bcl-2 mRNA expression significantly
decreases (P<0.01) and Bax mRNA expression signifi-
cantly increases (P<0.01) in the Lichong decoction
group. Pathological results showed that after treatment
of Lichong decoction, the uterine muscular layer obvi-
ously thinned, the muscle fiber had slight hypertrophy
or long and thin, and arranged regularly, the inserting
phenomenon of inner circular muscle and external lon-
gitudinal muscle occasionally was seen or was not seen,
and the uterine coefficient and the uterine transverse
diameter significantly decreased as compared with the
model control group (P<0.01). The above results indi-
cate that therapeutic action of Lichong decoction on
hysteromyoma is related with decrease of Bcl-2 mRNA
expression and increase of Bax mRNA expression, so as
to promote apoptosis of hysteromyoma.
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